Position-Adaptive Stimulation and Improved Pain Relief: Results of the RestoreSensor Study Lynn Webster, MD Lifetree Clinical Research and Pain Clinic,

Slides:



Advertisements
Similar presentations
London Bridge Hospital Orientation
Advertisements

PROCESS vs. WA State SCS Study A Comparison of Study Design, Patient Population, and Outcomes August 29,2007.
SHORT-TERM PATIENT REPORTED QUALITY OF LIFE AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY USING THE CONVALESCENCE AND RECOVERY EVALUATION (CARE) Abid Hussain.
® Introduction Low Back Pain and Physical Function Among Different Ethnicities Adelle A Safo, Sarah Holder DO, Sandra Burge PhD The University of Texas.
Efficacy of Cervical Spinal Cord Stimulation for Chronic Pain
Katie Rousseau Erich Richter, M.D. LSU Health Sciences Center, New Orleans.
Mapping of Posture-Dependent Shifts in Paresthesia during Spinal Cord Stimulation (SCS) Cong Yu MD 1, Thomas Yang MD 1, Shaun Kondamuri MD 2, Satish Dasari.
Successful Treatment of Low Back Pain with a Novel Neuromodulation Device Iris Smet, MD 1 Jean-Pierre Van Buyten, MD 1 Adnan Al-Kaisy MB ChB FRCA 2 1 AZ.
Short-term outcomes after endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis Kenneth Mandato,
1 OTC Omeprazole Magnesium (Prilosec 1 TM ) October 20, 2000 Larry Goldkind MD Division of Gastrointestinal and Coagulation Drug Products CDER, FDA.
Single Center Experience of Spinal Cord Stimulation in Chronic Abdominal Pain James R. Bruns, MD; Hammam H. Akbik, MD, Harsh Sachdeva, MD Department of.
CAUTION: The Spinal Modulation Axium™ Spinal Cord Stimulator System is an investigational device and is limited by United States law to investigational.
Ranjith Babu, MS 1 Jonathan Choi, MD 1 Adam Back, MD 1 Vijay Agarwal, MD 1 Matthew Hazzard, MD 1 Beatrice Ugiliweneza, MSPH PhD 2 Chirag G. Patil, MD MS.
Cost-effectiveness of Spinal Cord Stimulation for Failed Back Surgery Syndrome Using Rechargeable Equipment Richard B. North, MD 1  Rod S. Taylor, PhD.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
PERIPHERAL NERVE FIELD STIMULATION: MIRAGE OR REALITY? Dr Paul Verrills Interventional Pain Physician MBBS FAFMM MPainMed FIPP Metro Spinal Clinic, Australia.
Overview of Neurostimulation
Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.
Leadership Through Innovation Tm
THE EPIDEMIOLOGY OF BACK PAIN Environmental Health 5700UG.
® Introduction Back Pain Flare Ups, Physical Function, and Opioid Use Adriana Gonzalez, Darryl White MD, Sandra Burge PhD The University of Texas Health.
Management of HIV-Related Polyneuropathy with Spinal Cord Neuromodulation: A New Clinical Indication Management of HIV-Related Polyneuropathy with Spinal.
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
Ocular Comfort Assessment of Bepotastine Besilate Ophthalmic Solution 1.5% in Multicenter Conjunctival Allergen Challenge Clinical Trial JA Gow 1, TT Macejko.
Provider knowledge of California confidentiality laws: Associations with self-confidence and training Kapphahn C, MD, MPH 1, Rao S, MS, MPH 2, Jesser C,
Effect of hydrotherapy in the rehabilitative treatment of Multiple Sclerosis (MS) Volanti P, Scialabba G, De Cicco D. Neurorehabilitation Unit Fondazione.
2008 Student Satisfaction Survey. Survey Background Created to address the “Student Satisfaction” metric on the UNTHSC Strategy Map Developed by the Student.
SCS – Matching Therapy to Patient David L. Caraway, M.D., Ph.D. David L. Caraway, M.D., Ph.D. CEO, Medical Director Center for Pain Relief, Tri-State.
TAP PHARMACEUTICAL PRODUCTS INC. June 2, Arthritis Drugs Advisory Committee TAP Pharmaceutical Products Inc. June 2, 2004.
Persistence and Prevalence of MRSA on Ocular Surface following Primary MSSA/MRSA Infections Darlene Miller, DHSc, MPH, CIC David Almeida, MD, PhD Eduardo.
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
Efficacy and Tolerability of the Diclofenac Epolamine Patch in the Treatment of Minor Soft Tissue Injury W Carr, P Beks, C Jones, S Rovati, M Magelli,
Presented By: Mohammed Al-Issa. Objectives of the Study To assess the degree of satisfaction among dialysis patients in their dialytic therapy. To assess.
Disparities for Latino Children in the Receipt of Timely Medical Care David Brousseau MD, MS, Jennifer Yauck MS, Raymond Hoffmann PhD, Ann Nattinger MD,
Advanced Interventional Options for Chronic Pain October 9, 2105 Daniel Kwon, MD.
Spinal Cord Electrical Stimulation for Visceral Hypersensitivity in a Rodent Model of Functional Dyspepsia Geng-Qing Song and Jiande Chen Veterans Research.
Orthopedic Outcomes Measures for NF
Intra-wound Vancomycin Powder Significantly Reduces the Risk of Infection in Growth-friendly Surgery John T. Smith, MD Justin Haller, MD Angela Presson,
Spinal Cord Injury The average age of our patients with traumatic spinal cord injuries in 2013 was 46 years. The average age of our.
Statistical Considerations on NDA Sonia Castillo, Ph.D. Division of Biometrics 2 June 26, 2000.
Conclusions Sidney Cohen, MD Chairman, Department of Medicine Temple University School of Medicine Philadelphia, Pennsylvania Sidney Cohen, MD Chairman,
West Gables Rehabilitation Hospital 2015 Stakeholder Report: Brain Injury Program For more than 25 years, West Gables Rehabilitation Hospital has made.
Lauren K Lietzau, BS Linda N Meurer, MD, MPH Bernadette Witzack, MPS Linda Cieslik, PhD Ramona Williams, MSW Syed Ahmed, MD, DrPH Development and Evaluation.
METHODS The EASYTRAK 2 lead was studied along with the CONTAK  RENEWAL  2/4/4HE device in the Device Evaluation of the CONTAK RENEWAL 2/4/4HE with EASYTRAK.
PAIN & INTEROCEPTIVE BODY–AWARENESS
Sharon S. Allen, MD, PhD, Tracy Bade, MPH, Bruce A. Center, PhD,
Spinal Cord Stimulation (SCS): A proven surgical option for chronic pain Jeffrey M. Epstein, M.D. Babylon, NY.
Success of a repeated tined lead trial in a refractory OAB population
A Randomised Cross Over Comparison of Trehalose/Hyaluronate Eye Drops and Standard Treatment: Patient Satisfaction in the Treatment of Dry Eye Syndrome.
University of Arkansas for Medical Sciences Little Rock, Arkansas
37th International Conference of the IEEE Engineering in Medicine and Biology Milan, Italy, August 2015 Intense Therapy Ultrasound (ITU) for the Treatment.
Clinical Trial Results with OROS® Hydromorphone
A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain  Richard L. Rauck, MD, Mark S. Wallace,
Efficacy of simvastatin in plaque psoriasis: A pilot study
Trinity Amputation and Prosthesis Experience Scales Joanne Hebenton
FX006 Pivotal Ph 2b Data September , 2015
Classifying incomplete spinal cord injury syndromes: Algorithms based on the International Standards for Neurological and Functional Classification of.
Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee  Najib.
Acupuncture for Chronic Shoulder Pain in Persons With Spinal Cord Injury: A Small- Scale Clinical Trial  Trevor A. Dyson-Hudson, MD, Peter Kadar, CA, DiplAc,
Clinical Response to an Outpatient Palliative Care Consultation in Patients With Advanced Cancer and Cancer Pain  Sriram Yennurajalingam, MD, Jung Hun.
Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and.
Changes in Symptom Intensity Among Cancer Patients Receiving Outpatient Palliative Care  Jung Hun Kang, MD, PhD, Jung Hye Kwon, MD, PhD, David Hui, MD,
Spinal Cord Stimulation for Pain: Economic outcomes and cost-effectiveness analyses Brian Harris Kopell MD Departments of Neurosurgery, Neurology,
Strategies in Pain Management
The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, Opioid-Sparing Analgesic in Patients Undergoing Total Knee Arthroplasty  Lowell W Reynolds,
Alla Sikorskii, PhD, Charles W
No evidence for sex differences in the severity and treatment of cancer pain  Janet M. Edrington, RN, MS, Steven Paul, PhD, Marylin Dodd, RN, PhD, Claudia.
Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: First Report of the Five-Year Clinical Outcomes from.
The Effect of a Series of Repetitive Transcranial Magnetic Stimulations of the Motor Cortex on Central Pain After Spinal Cord Injury  Ruth Defrin, PhD,
Presentation transcript:

Position-Adaptive Stimulation and Improved Pain Relief: Results of the RestoreSensor Study Lynn Webster, MD Lifetree Clinical Research and Pain Clinic, Salt Lake City, UT David Schultz, MD MAPS Applied Research Center, Edina, MN Mark Sun, PhD Medtronic, Inc., Minneapolis, MN Ye Tan, MS Version 2.0, 30 Nov 2012

Presenter Disclosure Information Employee at Medtronic, Inc. RestoreSensor clinical study manager Version 2.0, 30 Nov 2012

Background For many patients, the intensity of spinal cord stimulation changes with body position1-3 Position-related changes in stimulation intensity may limit therapy efficacy and patient satisfaction4 A position-adaptive stimulation feature was developed to address these challenges Olin JC, Kidd DH, North RB. Postural changes in spinal cord perceptual thresholds. Neuromodulation. 1998;1:171–175. Cameron T, Aló KM. Effects of posture on stimulation parameters in spinal cord stimulation. Neuromodulation. 1998;1:177–183. 3. Abejón D, Feler C. Is impedance a parameter to be taken into account in spinal cord stimulation? Pain Physician. 2007;10:533–540. 4. Kuechmann C, Valine T, Wolfe D. Could automatic position-adaptive stimulation be useful in spinal cord stimulation? 2009. Poster presented at: 6th Congress of the European Federation of ISAP® Chapters (EFIC); September 9–12, 2009; Lisbon, Portugal. Version 2.0, 30 Nov 2012

Background RestoreSensor study demonstrated the clinical benefits of position-adaptive stimulation5 5. Schultz DM, Webster L, Kosek P, Dar U, Tan Y, Sun M. Sensor-driven position-adaptive spinal cord stimulation for chronic pain. Pain Physician. 2012;15:1-12. Version 2.0, 30 Nov 2012

Study Design Version 2.0, 30 Nov 2012

Patients Patients enrolled: N = 79 at 10 US study centers Age: 52.6 (27 - 85) years Female: 60%, N = 47 Male: 40%, N = 32 Baseline average NPRS scores: 6.1 (2.7 - 10) Version 2.0, 30 Nov 2012 6

Pain Etiologies Version 2.0, 30 Nov 2012

Dual Primary Efficacy Objective Improved pain relief with no loss of convenience and/or Improved convenience with no loss of pain relief Version 2.0, 30 Nov 2012

Assessment of Pain Relief: Primary Efficacy Objective Assessment: Two Separate 5-Point Likert Scales Assessment of Pain Relief: Assessment of Convenience: 1 2 3 4 5 Much worse Somewhat worse No difference Somewhat better Much better Much less Somewhat less No difference Somewhat more Much more Version 2.0, 30 Nov 2012

Composite Primary Efficacy Results: Improved Pain Relief and/or Convenience 86.5% p<0.001 Predefined acceptance threshold Version 2.0, 30 Nov 2012 10

Improved Pain Relief Version 2.0, 30 Nov 2012

Improved Convenience Version 2.0, 30 Nov 2012

Conclusions Position-adaptive stimulation improved pain relief and/or convenience for most patients when compared with conventional stimulation Reported improvements in pain relief and/or convenience may lead to greater overall patient satisfaction with spinal cord stimulation therapy Version 2.0, 30 Nov 2012